世界のA型肝炎ウイルス細胞受容体2市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21JY00001)
◆英語タイトル:Global Hepatitis A Virus Cellular Receptor 2 Market 2021 by Company, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21JY00001
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:95
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、A型肝炎ウイルス細胞受容体2の世界市場を広く調査・分析し、今後の市場展望をまとめております。A型肝炎ウイルス細胞受容体2の種類別市場規模(IMM-1802、LY-3321367、MCLA-134、CA-170、CA-327、ENUM-005、その他)、用途別市場規模(結腸がん、骨髄異形成症候群、非小細胞肺がん、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Aurigene Discovery Technologies Ltd、BeiGene Ltd、Eli Lilly and Co、Enumeral Biomedical Holdings Inc、Incyte Corp、Interprotein Corp、Jounce Therapeutics Inc、Merus NV、Novartis AG、Sorrento Therapeutics Inc、Sutro Biopharma Inc、Tesaro Inc、Trellis Bioscience Inc
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:IMM-1802、LY-3321367、MCLA-134、CA-170、CA-327、ENUM-005、その他
・用途別分析2016年-2026年:結腸がん、骨髄異形成症候群、非小細胞肺がん、その他
・A型肝炎ウイルス細胞受容体2の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・A型肝炎ウイルス細胞受容体2のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・A型肝炎ウイルス細胞受容体2のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・A型肝炎ウイルス細胞受容体2の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・A型肝炎ウイルス細胞受容体2の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Hepatitis A Virus Cellular Receptor 2 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Hepatitis A Virus Cellular Receptor 2 size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Hepatitis A Virus Cellular Receptor 2 market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Hepatitis A Virus Cellular Receptor 2 market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
IMM-1802
LY-3321367
MCLA-134
CA-170
CA-327
ENUM-005
Others

Market segment by Application, can be divided into
Colon Cancer
Myelodysplastic
Non-Small Cell Lung Cancer
Others

Market segment by players, this report covers
Aurigene Discovery Technologies Ltd
BeiGene Ltd
Eli Lilly and Co
Enumeral Biomedical Holdings Inc
Incyte Corp
Interprotein Corp
Jounce Therapeutics Inc
Merus NV
Novartis AG
Sorrento Therapeutics Inc
Sutro Biopharma Inc
Tesaro Inc
Trellis Bioscience Inc

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Hepatitis A Virus Cellular Receptor 2 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Hepatitis A Virus Cellular Receptor 2, with revenue, gross margin and global market share of Hepatitis A Virus Cellular Receptor 2 from 2019 to 2021.
Chapter 3, the Hepatitis A Virus Cellular Receptor 2 competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Hepatitis A Virus Cellular Receptor 2 market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Hepatitis A Virus Cellular Receptor 2 research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Product Overview and Scope of Hepatitis A Virus Cellular Receptor 2
1.2 Classification of Hepatitis A Virus Cellular Receptor 2 by Type
1.2.1 Overview: Global Hepatitis A Virus Cellular Receptor 2 Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Type in 2020
1.2.3 IMM-1802
1.2.4 LY-3321367
1.2.5 MCLA-134
1.2.6 CA-170
1.2.7 CA-327
1.2.8 ENUM-005
1.2.9 Others
1.3 Global Hepatitis A Virus Cellular Receptor 2 Market by Application
1.3.1 Overview: Global Hepatitis A Virus Cellular Receptor 2 Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Colon Cancer
1.3.3 Myelodysplastic
1.3.4 Non-Small Cell Lung Cancer
1.3.5 Others
1.4 Global Hepatitis A Virus Cellular Receptor 2 Market Size & Forecast
1.5 Global Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast by Region
1.5.1 Global Hepatitis A Virus Cellular Receptor 2 Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Hepatitis A Virus Cellular Receptor 2 Market Size by Region, (2016-2021)
1.5.3 North America Hepatitis A Virus Cellular Receptor 2 Market Size and Prospect (2016-2026)
1.5.4 Europe Hepatitis A Virus Cellular Receptor 2 Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size and Prospect (2016-2026)
1.5.6 South America Hepatitis A Virus Cellular Receptor 2 Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Hepatitis A Virus Cellular Receptor 2 Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Hepatitis A Virus Cellular Receptor 2 Market Drivers
1.6.2 Hepatitis A Virus Cellular Receptor 2 Market Restraints
1.6.3 Hepatitis A Virus Cellular Receptor 2 Trends Analysis
2 Company Profiles
2.1 Aurigene Discovery Technologies Ltd
2.1.1 Aurigene Discovery Technologies Ltd Details
2.1.2 Aurigene Discovery Technologies Ltd Major Business
2.1.3 Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.1.4 Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Aurigene Discovery Technologies Ltd Recent Developments and Future Plans
2.2 BeiGene Ltd
2.2.1 BeiGene Ltd Details
2.2.2 BeiGene Ltd Major Business
2.2.3 BeiGene Ltd Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.2.4 BeiGene Ltd Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 BeiGene Ltd Recent Developments and Future Plans
2.3 Eli Lilly and Co
2.3.1 Eli Lilly and Co Details
2.3.2 Eli Lilly and Co Major Business
2.3.3 Eli Lilly and Co Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.3.4 Eli Lilly and Co Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Eli Lilly and Co Recent Developments and Future Plans
2.4 Enumeral Biomedical Holdings Inc
2.4.1 Enumeral Biomedical Holdings Inc Details
2.4.2 Enumeral Biomedical Holdings Inc Major Business
2.4.3 Enumeral Biomedical Holdings Inc Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.4.4 Enumeral Biomedical Holdings Inc Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Enumeral Biomedical Holdings Inc Recent Developments and Future Plans
2.5 Incyte Corp
2.5.1 Incyte Corp Details
2.5.2 Incyte Corp Major Business
2.5.3 Incyte Corp Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.5.4 Incyte Corp Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Incyte Corp Recent Developments and Future Plans
2.6 Interprotein Corp
2.6.1 Interprotein Corp Details
2.6.2 Interprotein Corp Major Business
2.6.3 Interprotein Corp Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.6.4 Interprotein Corp Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Interprotein Corp Recent Developments and Future Plans
2.7 Jounce Therapeutics Inc
2.7.1 Jounce Therapeutics Inc Details
2.7.2 Jounce Therapeutics Inc Major Business
2.7.3 Jounce Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.7.4 Jounce Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Jounce Therapeutics Inc Recent Developments and Future Plans
2.8 Merus NV
2.8.1 Merus NV Details
2.8.2 Merus NV Major Business
2.8.3 Merus NV Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.8.4 Merus NV Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Merus NV Recent Developments and Future Plans
2.9 Novartis AG
2.9.1 Novartis AG Details
2.9.2 Novartis AG Major Business
2.9.3 Novartis AG Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.9.4 Novartis AG Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Novartis AG Recent Developments and Future Plans
2.10 Sorrento Therapeutics Inc
2.10.1 Sorrento Therapeutics Inc Details
2.10.2 Sorrento Therapeutics Inc Major Business
2.10.3 Sorrento Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.10.4 Sorrento Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Sorrento Therapeutics Inc Recent Developments and Future Plans
2.11 Sutro Biopharma Inc
2.11.1 Sutro Biopharma Inc Details
2.11.2 Sutro Biopharma Inc Major Business
2.11.3 Sutro Biopharma Inc Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.11.4 Sutro Biopharma Inc Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Sutro Biopharma Inc Recent Developments and Future Plans
2.12 Tesaro Inc
2.12.1 Tesaro Inc Details
2.12.2 Tesaro Inc Major Business
2.12.3 Tesaro Inc Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.12.4 Tesaro Inc Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Tesaro Inc Recent Developments and Future Plans
2.13 Trellis Bioscience Inc
2.13.1 Trellis Bioscience Inc Details
2.13.2 Trellis Bioscience Inc Major Business
2.13.3 Trellis Bioscience Inc Hepatitis A Virus Cellular Receptor 2 Product and Solutions
2.13.4 Trellis Bioscience Inc Hepatitis A Virus Cellular Receptor 2 Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Trellis Bioscience Inc Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Hepatitis A Virus Cellular Receptor 2 Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Hepatitis A Virus Cellular Receptor 2 Players Market Share
3.2.2 Top 10 Hepatitis A Virus Cellular Receptor 2 Players Market Share
3.2.3 Market Competition Trend
3.3 Hepatitis A Virus Cellular Receptor 2 Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Hepatitis A Virus Cellular Receptor 2 Revenue and Market Share by Type (2016-2021)
4.2 Global Hepatitis A Virus Cellular Receptor 2 Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Hepatitis A Virus Cellular Receptor 2 Revenue Market Share by Application (2016-2021)
5.2 Hepatitis A Virus Cellular Receptor 2 Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2016-2026)
6.2 North America Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2016-2026)
6.3 North America Hepatitis A Virus Cellular Receptor 2 Market Size by Country
6.3.1 North America Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2016-2026)
6.3.2 United States Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
6.3.3 Canada Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
6.3.4 Mexico Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2016-2026)
7.2 Europe Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2016-2026)
7.3 Europe Hepatitis A Virus Cellular Receptor 2 Market Size by Country
7.3.1 Europe Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2016-2026)
7.3.2 Germany Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
7.3.3 France Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
7.3.5 Russia Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
7.3.6 Italy Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2016-2026)
8.2 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2016-2026)
8.3 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Market Size by Region
8.3.1 Asia-Pacific Hepatitis A Virus Cellular Receptor 2 Revenue by Region (2016-2026)
8.3.2 China Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
8.3.3 Japan Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
8.3.4 South Korea Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
8.3.5 India Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
8.3.7 Australia Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2016-2026)
9.2 South America Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2016-2026)
9.3 South America Hepatitis A Virus Cellular Receptor 2 Market Size by Country
9.3.1 South America Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2016-2026)
9.3.2 Brazil Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
9.3.3 Argentina Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Revenue by Type (2016-2026)
10.2 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Revenue by Application (2016-2026)
10.3 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Market Size by Country
10.3.1 Middle East & Africa Hepatitis A Virus Cellular Receptor 2 Revenue by Country (2016-2026)
10.3.2 Turkey Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
10.3.4 UAE Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

...

【掲載企業】

Aurigene Discovery Technologies Ltd、BeiGene Ltd、Eli Lilly and Co、Enumeral Biomedical Holdings Inc、Incyte Corp、Interprotein Corp、Jounce Therapeutics Inc、Merus NV、Novartis AG、Sorrento Therapeutics Inc、Sutro Biopharma Inc、Tesaro Inc、Trellis Bioscience Inc

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のA型肝炎ウイルス細胞受容体2市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global Hepatitis A Virus Cellular Receptor 2 Market 2021 by Company, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。